ATE215814T1 - Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit - Google Patents

Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit

Info

Publication number
ATE215814T1
ATE215814T1 AT96933492T AT96933492T ATE215814T1 AT E215814 T1 ATE215814 T1 AT E215814T1 AT 96933492 T AT96933492 T AT 96933492T AT 96933492 T AT96933492 T AT 96933492T AT E215814 T1 ATE215814 T1 AT E215814T1
Authority
AT
Austria
Prior art keywords
agent
estrogen
lipophilic
pct
suspension
Prior art date
Application number
AT96933492T
Other languages
English (en)
Inventor
Catherine Meignant
Original Assignee
Innothera Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innothera Sa Lab filed Critical Innothera Sa Lab
Application granted granted Critical
Publication of ATE215814T1 publication Critical patent/ATE215814T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT96933492T 1995-10-05 1996-10-04 Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit ATE215814T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511732A FR2739558B1 (fr) 1995-10-05 1995-10-05 Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
PCT/FR1996/001555 WO1997012600A1 (fr) 1995-10-05 1996-10-04 Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale

Publications (1)

Publication Number Publication Date
ATE215814T1 true ATE215814T1 (de) 2002-04-15

Family

ID=9483283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96933492T ATE215814T1 (de) 1995-10-05 1996-10-04 Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit

Country Status (10)

Country Link
US (1) US6060077A (de)
EP (1) EP0861067B1 (de)
JP (1) JPH11514994A (de)
CN (1) CN1198665A (de)
AT (1) ATE215814T1 (de)
AU (1) AU7220496A (de)
CA (1) CA2233919A1 (de)
DE (1) DE69620625D1 (de)
FR (1) FR2739558B1 (de)
WO (1) WO1997012600A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
CA2418135C (en) 2000-08-03 2011-09-20 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US7018992B2 (en) 2000-12-15 2006-03-28 Novo Nordisk A/S Hormone composition
EP3747443A3 (de) 2000-12-15 2021-03-03 Novo Nordisk Health Care AG Verwendung eines östrogens bei der herstellung einer östrogenhaltigen zusammensetzung zur behandlung von atrophischer vaginitis
US7658941B2 (en) * 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
CA2484318C (en) * 2002-05-01 2014-01-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant antifungal gel compositions
US7417013B2 (en) * 2002-05-01 2008-08-26 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7695730B2 (en) * 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US20040167039A1 (en) * 2002-05-01 2004-08-26 Nawaz Ahmad Warming and nonirritating lubricant compositions and method of comparing irritation
US20040185065A1 (en) * 2002-05-01 2004-09-23 Nawaz Ahmad Warming and nonirritating lubricant compositions and method of comparing irritation
MXPA04010890A (es) * 2002-05-01 2005-07-14 Johnson & Johnson Composiciones lubricantes anhidras generadoras de calor y no irritantes.
AU2003239869A1 (en) * 2002-05-23 2003-12-12 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス,インコーポレイティド 制御放出製剤
CA2538856C (en) * 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US20090053163A1 (en) * 2003-10-30 2009-02-26 Nawaz Ahmad Warming and nonirritating lubricant compositions and method of comparing irritation
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US6949067B1 (en) 2004-05-11 2005-09-27 Dann Jeffrey A Device and method for enhancing female sexual stimulation
US8147399B2 (en) 2004-05-11 2012-04-03 Gloth David A Device and method for applying a biocompatible substance to a female stimulation device
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
GT200500315A (es) * 2004-11-02 2006-06-06 Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CA2612380C (en) * 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
CN101232869B (zh) * 2005-06-16 2016-03-02 沃纳奇尔科特有限责任公司 局部给药的凝胶组合物
US20070036848A1 (en) * 2005-08-12 2007-02-15 Drugtech Corporation Estrogen compositions and therapeutic methods of use thereof
US7851419B2 (en) * 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
CN101351196B (zh) * 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
WO2007076144A2 (en) * 2005-12-27 2007-07-05 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20070172965A1 (en) * 2006-01-23 2007-07-26 Kangguo Cheng Non-destructive trench volume determination and trench capacitance projection
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (de) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und -therapien
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
RU2740059C2 (ru) * 2012-06-18 2020-12-31 Терапьютиксмд, Инк. Капсулы с растворимым эстрадиолом для интравагинального введения
US10806697B2 (en) * 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) * 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) * 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
BR112015022946A8 (pt) 2013-03-15 2022-11-29 Warner Chilcott Co Llc Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada
BR112016009008B8 (pt) * 2013-10-22 2023-01-31 Therapeuticsmd Inc Uso de estradiol e/ou hemi-hidrato de estradiol e de um agente solubilizante compreendendo um óleo de cadeia média para a preparação de um pessário para o tratamento de atrofia vulvovaginal e pessário que compreende estradiol
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180100567A (ko) * 2015-12-07 2018-09-11 쎄러퓨틱스엠디, 인코퍼레이티드 질 삽입식 에스트라디올 약제학적 조성물 및 방법
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration

Also Published As

Publication number Publication date
FR2739558A1 (fr) 1997-04-11
JPH11514994A (ja) 1999-12-21
FR2739558B1 (fr) 1997-11-28
CA2233919A1 (fr) 1997-04-10
EP0861067B1 (de) 2002-04-10
AU7220496A (en) 1997-04-28
US6060077A (en) 2000-05-09
CN1198665A (zh) 1998-11-11
EP0861067A1 (de) 1998-09-02
WO1997012600A1 (fr) 1997-04-10
DE69620625D1 (de) 2002-05-16

Similar Documents

Publication Publication Date Title
DE69620625D1 (de) Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit
Mishell Jr et al. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrel
DE69605899D1 (de) Gel zur lokalen hormontherapie der vaginalen trockenheit
US4816257A (en) Method for producing an in vivo environment suitable for human embryo transfer
US4186742A (en) Contraceptive-antivenereal disease tampon
FR2728464B1 (fr) Forme galenique unitaire, son procede d'obtention et ses utilisations
ES2337129T3 (es) Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
DE69133214D1 (de) Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung
PT92131B (pt) Processo para a preparacao de meios para aplicacao transdermica contendo gestodeno
JPH10510825A (ja) 17β−エストラジオール前駆体の投与のための膣内薬剤送出製剤
EP1087773A4 (de) Abgabeverfahren und formulierungen für vaginalwirkstoffe
CN101351188A (zh) 雌激素组合物和应用它们的治疗方法
Laurikka-Routti et al. A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry
Ladipo et al. Contraceptive implants
Price et al. Effect of the suppository base on progesterone delivery from the vagina
Sitruk-Ware Transdermal application of steroid hormones for contraception
Murray Natural progesterone: what role in women’s health care
Lähteenmäki et al. Novel delivery systems in contraception
Simon et al. Polysiloxane vaginal rings and cylinders for physiologic endometrial priming in functionally agonadal women
Englund et al. Endometrial effect of vaginal estriol treatment: a scanning electron microscopic study of the luminal surface
Chvapil et al. Collagen sponge in gynecologic use
JPH024576B2 (de)
Zañartu et al. Steroid release from polymer vaginal devices. Effect on fertility inhibition
Potts et al. Where next with long-acting steroids?
Moghadam et al. Advances in menopausal hormonal therapy delivery systems: a comparative review

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties